Please wait while the formulary information is being retrieved.
SALAGEN (PILOCARPINE HCL)
- Xerostomia
- Xerostomia secondary to radiation therapy
- Xerostomia secondary to sjogren's syndrome
(pilocarpine) 5 mg tablet
- 1 tablet (5 mg) by oral route 3 times per day
(pilocarpine) 7.5 mg tablet
- 1 tablet (7.5 mg) by oral route 2 times per day
pilocarpine 5 mg tablet
- 1 tablet (5 mg) by oral route 3 times per day
pilocarpine 7.5 mg tablet
- 1 tablet (7.5 mg) by oral route 2 times per day
Xerostomia
- 1 tablet (5 mg) by oral route 3 times per day
- 2 tablets (10 mg) by oral route 3 times per day
- 1 tablet (7.5 mg) by oral route 3 times per day
- 1 tablet (7.5 mg) by oral route 2 times per day
- 1 tablet (7.5 mg) by oral route 4 times per day
Xerostomia secondary to sjogren's syndrome
- 1 tablet (5 mg) by oral route 4 times per day
- None
Contraindicated
- None
Severe
Moderate
- dextromethorphan-quinidine
- Nuedexta
- quinidine gluconate
- quinidine sulfate
- Acute asthma attack
- Angle-closure glaucoma
- Iritis
Contraindicated
- Biliary calculus
- Biliary tract disorder
- Bronchospastic pulmonary disease
- Cholecystitis
- Chronic obstructive pulmonary disease
- Psychiatric disorder
- Retinal detachment
- Severe hepatic disease
Severe
Moderate
- Hypertension
- Hypotension
- Kidney stone
SALAGEN (PILOCARPINE HCL)
- Xerostomia
- Xerostomia secondary to radiation therapy
- Xerostomia secondary to sjogren's syndrome
- None
- Hyperhidrosis
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- Chills
- Diarrhea
- Dizziness
- Dyspepsia
- Dysphagia
- Edema
- Epistaxis
- Fatigue
- Flushing
- Headache disorder
- Hypertension
- Increased urinary frequency
- Nausea
- Rhinitis
- Tachycardia
- Tremor
- Visual changes
- Voice change
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Pilocarpine (oral)
Safety and efficacy not established in pediatrics.
- 1 Day – 18 Years
- Safety and efficacy not established in pediatrics.
Pilocarpine
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Pilocarpine (oral, Ophth)
Insufficient data avail;Molecular wt low enough for poss. Breastmilk excretion
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data avail;Molecular wt low enough for poss. Breastmilk excretion |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Xerostomia | |
| K11.7 | Disturbances of salivary secretion |
| R68.2 | Dry mouth, unspecified |
| Xerostomia secondary to radiation therapy | |
| K11.7 | Disturbances of salivary secretion |
| R68.2 | Dry mouth, unspecified |
| Xerostomia secondary to sjogren's syndrome | |
| M35.00 | Sicca syndrome, unspecified |
| 0-9 | A-Z |
|---|---|
| K11.7 | Disturbances of salivary secretion |
| K11.7 | Disturbances of salivary secretion |
| M35.00 | Sicca syndrome, unspecified |
| R68.2 | Dry mouth, unspecified |
| R68.2 | Dry mouth, unspecified |
Formulary Reference Tool